The incidence of IPF and other pulmonary disorders increases with age independent of exposure to common environmental risk factors. Little is known about how age increases the risk for lung diseases. The lack of understanding the relationship between aging and the inability of the lung to repair after injury, as occurs in IPF, leads to an urgent need for more research in the field. Our own work has demonstrated an increase of susceptibility to chronic lung injury in aged mice. Additionally, we have described that bone marrow derived mesenchymal stem cells (B-MSCs) obtained from old mice are deficient in their multi-linage potential and in their capacity to respond to soluble factors. However, what are the biological consequences of an aged endogenous B-MSCs and why they exhibit a functional impairment is not well known. Our published and preliminary data supports the overarching and unique hypothesis that defective lung repair in aging is associated with dysfunctional activation, proliferation, and mobilization of B-MSCs. In the present revised project, we will focus on the effect of age on B-MSCs biology by comparing B-MSCs isolated from young and old donors and in the characteristics of B-MSCs during chronic Injury, by comparing B-MSCs isolated from IPF patients and age-matched and young controls. We are confident this will help us to understand the pathogenesis of other age-associated lung diseases and provide insights for the development of novel strategies for tissue repair.
Because the incidence of different types of pulmonary diseases increases with age, independent of exposure to common environmental risk factors. Recently, we have documented functional differences in bone marrow derived mesenchymal stem cells (B-MSCs) between young and old animals, B-MSCs exhibit functional impairments that are not well explained. This observation leads us into our hypothesis that B-MSCs exhibit age-related senescence and decreased effectiveness to participate in the process of lung repair.
|Kitsios, Georgios D; Rojas, Mauricio; Kass, Daniel J et al. (2018) Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis. Thorax 73:481-484|
|Cárdenes, Nayra; Álvarez, Diana; Sellarés, Jacobo et al. (2018) Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis. Stem Cell Res Ther 9:257|
|D'Cunha, Hannah C; Rojas, Mauricio (2018) Ex Vivo Lung Perfusion: Past, Present, and Future. ASAIO J 64:135-139|
|Zank, Daniel C; Bueno, Marta; Mora, Ana L et al. (2018) Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics. Front Med (Lausanne) 5:10|
|Weathington, Nathaniel M; Álvarez, Diana; Sembrat, John et al. (2018) Ex vivo lung perfusion as a human platform for preclinical small molecule testing. JCI Insight 3:|
|Coppin, Emilie; Florentin, Jonathan; Vasamsetti, Sathish Babu et al. (2018) Splenic hematopoietic stem cells display a pre-activated phenotype. Immunol Cell Biol :|
|Bueno, Marta; Brands, Judith; Voltz, Lauren et al. (2018) ATF3 represses PINK1 gene transcription in lung epithelial cells to control mitochondrial homeostasis. Aging Cell 17:|
|Mora, Ana L; Rojas, Mauricio (2017) Seeing CO in a New Light: Enhancing Autophagy in Mesenchymal Stromal Cells and Implications for Cell Therapy. Am J Respir Cell Mol Biol 56:275-276|
|Meijles, Daniel N; Sahoo, Sanghamitra; Al Ghouleh, Imad et al. (2017) The matricellular protein TSP1 promotes human and mouse endothelial cell senescence through CD47 and Nox1. Sci Signal 10:|
|Weathington, Nathaniel M; Kanth, Shreya M; Gong, Qiaoke et al. (2017) IL-4 Induces IL17Rb Gene Transcription in Monocytic Cells with Coordinate Autocrine IL-25 Signaling. Am J Respir Cell Mol Biol 57:346-354|
Showing the most recent 10 out of 26 publications